ROS-directed Cancer Chemotherapeutics
Recent research demonstrates that redox dysregulation originating from metabolic alterations and dependence on mitogenic and survival signaling through ROS represents a specific vulnerability of malignant cells that can be selectively targeted by pro- and antioxidant redox chemotherapeutics.
Read more about this topic: Reactive Oxygen Species
Famous quotes containing the word cancer:
“I wish more and more that health were studied half as much as disease is. Why, with all the endowment of research against cancer is no study made of those who are free from cancer? Why not inquire what foods they eat, what habits of body and mind they cultivate? And why never study animals in health and natural surroundings? why always sickened and in an environment of strangeness and artificiality?”
—Sarah N. Cleghorn (19761959)